Q2 2026 saw a 9.8% revenue decline year-over-year, with net income dropping to $70 million and Adjusted EBITDA down 13.2%. Divestitures reduced hospital count and proceeds were used for debt repurchases. 2026 guidance projects $11.4–$11.6 billion in revenue and a net loss per share.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.